Ixazomib Maintenance Study in Patients With AL Amyloidosis
study id #: NCT03618537
condition: AL Amyloidosis
status: Recruiting
purpose:The purpose of this study is to learn if Ixazomib maintenance treatment (chemotherapy) works to control the disease. Through this study, the investigators hope to learn more about ways to prevent or delay relapse of AL Amyloidosis.
intervention: Ixazomib, Dexamethasone
results: https://clinicaltrials.gov/ct2/show/results/NCT03618537
last updated: September 17, 2021
-
Systemic AmyloidosisTissue deposition of protein fibrils cau...
-
Why There’s New Hope if You Have Cardiac AmyloidosisAmyloidosis is a disorder in which c...
-
David Dingli, MD, PhDDr. David Dingli is a hematology and int...
-
Safety and Efficacy of Long-Term Diflunisal Administration in Hereditary Transthyretin (ATTR) AmyloidosisBackground: A recent 2-year randomized ...
-
Light-Chain Cardiac AmyloidosisCardiac amyloidosis is an underrecognize...
-
Raymond L. Comenzo, MDDr. Raymond Comenzo received his medic...
-
University of Chicago Medicine Cardiac Amyloidosis ProgramThe University of Chicago Medicine is on...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.